ATE234614T1 - Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren - Google Patents
Verwendung von selegilin zur behandlung von gehörverlust bei säugetierenInfo
- Publication number
- ATE234614T1 ATE234614T1 AT96917093T AT96917093T ATE234614T1 AT E234614 T1 ATE234614 T1 AT E234614T1 AT 96917093 T AT96917093 T AT 96917093T AT 96917093 T AT96917093 T AT 96917093T AT E234614 T1 ATE234614 T1 AT E234614T1
- Authority
- AT
- Austria
- Prior art keywords
- selegiline
- mammals
- hearing loss
- treat hearing
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/475,186 US5561163A (en) | 1990-08-31 | 1995-06-07 | Treating hearing loss with deprenyl |
PCT/US1996/008642 WO1996040094A1 (en) | 1995-06-07 | 1996-06-03 | Use of selegiline to treat hearing loss in mammals |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE234614T1 true ATE234614T1 (de) | 2003-04-15 |
Family
ID=23886552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96917093T ATE234614T1 (de) | 1995-06-07 | 1996-06-03 | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren |
Country Status (9)
Country | Link |
---|---|
US (1) | US5561163A (de) |
EP (1) | EP0831798B1 (de) |
JP (1) | JP3094305B2 (de) |
AT (1) | ATE234614T1 (de) |
AU (1) | AU693704B2 (de) |
CA (1) | CA2221255C (de) |
DE (1) | DE69626816T2 (de) |
ES (1) | ES2194104T3 (de) |
WO (1) | WO1996040094A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050222127A1 (en) * | 2004-03-30 | 2005-10-06 | Alcon, Inc. | Use of Rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance |
MXPA06014018A (es) | 2004-06-01 | 2007-02-08 | Hoffmann La Roche | 3-amino-1-arilpropil-indoles como inhibidores de reabsorcion de monoaminas. |
HUE057521T2 (hu) | 2013-03-14 | 2022-05-28 | Brigham & Womens Hospital Inc | Készítmények és eljárások epithelialis õssejtek szaporítására és tenyésztésére |
EP3189134A1 (de) | 2014-09-03 | 2017-07-12 | The Brigham and Women's Hospital, Inc. | Zusammensetzungen, systeme und verfahren zur erzeugung von innenohrhaarzellen zur behandlung von gehörverlust |
EP3400286A1 (de) | 2016-01-08 | 2018-11-14 | Massachusetts Institute Of Technology | Herstellung von differenzierten enteroendokrinen zellen und insulinproduzierenden zellen |
US10213511B2 (en) | 2016-03-02 | 2019-02-26 | Frequency Therapeutics, Inc. | Thermoreversible compositions for administration of therapeutic agents |
US11260130B2 (en) | 2016-03-02 | 2022-03-01 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV |
US10201540B2 (en) | 2016-03-02 | 2019-02-12 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I |
CA3048220A1 (en) | 2016-12-30 | 2018-07-05 | Frequency Therapeutics, Inc. | 1h-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells |
US11162071B2 (en) | 2018-08-17 | 2021-11-02 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by upregulating JAG-1 |
WO2020037326A1 (en) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by downregulating foxo |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA871155A (en) * | 1971-05-18 | Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt | Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation | |
HU187775B (en) * | 1982-07-14 | 1986-02-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu | New process for producing propargile-amines of pharmaceutical activity |
HU193662B (en) * | 1983-12-20 | 1987-11-30 | Chinoin Gyogyszer Es Vegyeszet | Process for producing synergetic pharmaceutical composition of antidepressive aktivity |
US4916151A (en) * | 1985-12-05 | 1990-04-10 | Merrell Dow Pharmaceuticals Inc. | Method of treating parkinson's syndrome |
US4871550A (en) * | 1986-09-05 | 1989-10-03 | Millman Phillip L | Nutrient composition for athletes and method of making and using the same |
US4861800A (en) * | 1987-08-18 | 1989-08-29 | Buyske Donald A | Method for administering the drug deprenyl so as to minimize the danger of side effects |
US5192808A (en) * | 1990-08-31 | 1993-03-09 | Deprenyl Animal Health, Inc. | Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease) |
CA2039194C (en) * | 1990-08-31 | 1997-01-28 | Norton W. Milgram | Uses of l-deprenyl and compositions for same |
SE9301112D0 (sv) * | 1993-04-02 | 1993-04-02 | Orion-Yhtymae Oy | A new composition |
-
1995
- 1995-06-07 US US08/475,186 patent/US5561163A/en not_active Expired - Lifetime
-
1996
- 1996-06-03 CA CA002221255A patent/CA2221255C/en not_active Expired - Lifetime
- 1996-06-03 WO PCT/US1996/008642 patent/WO1996040094A1/en active IP Right Grant
- 1996-06-03 ES ES96917093T patent/ES2194104T3/es not_active Expired - Lifetime
- 1996-06-03 EP EP96917093A patent/EP0831798B1/de not_active Expired - Lifetime
- 1996-06-03 AU AU59772/96A patent/AU693704B2/en not_active Ceased
- 1996-06-03 JP JP09501174A patent/JP3094305B2/ja not_active Expired - Fee Related
- 1996-06-03 DE DE69626816T patent/DE69626816T2/de not_active Expired - Fee Related
- 1996-06-03 AT AT96917093T patent/ATE234614T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1996040094A1 (en) | 1996-12-19 |
JPH10510843A (ja) | 1998-10-20 |
AU693704B2 (en) | 1998-07-02 |
JP3094305B2 (ja) | 2000-10-03 |
CA2221255A1 (en) | 1996-12-19 |
DE69626816T2 (de) | 2004-02-05 |
DE69626816D1 (de) | 2003-04-24 |
AU5977296A (en) | 1996-12-30 |
EP0831798A1 (de) | 1998-04-01 |
ES2194104T3 (es) | 2003-11-16 |
CA2221255C (en) | 2005-11-08 |
EP0831798B1 (de) | 2003-03-19 |
US5561163A (en) | 1996-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE9700225A (et) | Meetod diabetes mellituse raviks, kasutades KKF | |
ATE254405T1 (de) | Stoff zur erhöhung der effizienz der vermehrung und der produktion von säugetieren | |
DE69733132D1 (de) | Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen | |
NZ330860A (en) | Method of inhibiting photoaging of skin | |
ATE225176T1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
DE59409832D1 (de) | Pflaster zur behandlung von nagelmykosen | |
ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
DE59509848D1 (de) | Kombinationspräparat zur anwendung bei immunologischen erkrankungen | |
ID22042A (id) | Benzonaftiridin sebagai pengobatan cabang tenggorokan | |
ATE311853T1 (de) | Verwendung von krillenzymen zur behandlung von zahnbelag | |
ATE234614T1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
ATE218862T1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen | |
ATE226058T1 (de) | Verwendung von lysin zur behandlung des haarausfalls | |
ATE251462T1 (de) | Verfahren zur behandlung von narbengewebe | |
ATE236633T1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
ATE278401T1 (de) | Verwendung von riluzol zur behandlung von akustischen traumazuständen | |
DE69936779D1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
DE69712287T2 (de) | Verwendung von Sulbutiamin zur Behandlung von psychomotorischen oder psychointellektuellen Beschwerden | |
NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
ATE209910T1 (de) | Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständen | |
DE69636412D1 (de) | Ginkolide zur hemmung der membranexpression | |
UA36485A (uk) | Спосіб лікування генералізованого пародонтиту |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |